Game Changers: Expanding Therapeutic Options Across the Subspecialties (CME)

Multi-Disciplinary Update: 

Game Changers: Expanding Therapeutic Options

Across the Subspecialties

Recorded on and Last Review Date:  Friday, April 3, 2020

Wills Eye Hospital, 840 Walnut Street, Philadelphia, PA (Auditorium -- 8th Floor)

Zeba A. Syed, MD

 Program Chair 

Course Description: 

This conference will update participants on the latest medications and technologies available across various subspecialties. The goal of this program is to guide participants on the newest options and how to provide them for patients or refer to the appropriate sub-specialist.

At the conclusion of this conference, participants should be able to:

·      Recognize new and “game-changing” medication options across the subspecialties (e.g. teprotumumab for thyroid eye disease, cenegermin for neurotrophic keratitis, bimatoprost sustained–release implant for glaucoma).

·      Identify new technology and surgery across the subspecies (e.g. video games for amblyopia therapy, new MIGS options).

·      Understand when and how to provide these novel options to patients, or to provide direction on referral to the appropriate sub-specialist.

Wills Eye Hospital Faculty:             

Natasha N. Kolomeyer, MD•  Jade M. Price, MD • Aakriti G. Shukla, MD • Alison H. Watson, MD


Introduction • Zeba A. Syed, MD

Tepezza (Teprotumumab) for the Management of Thyroid Eye Disease • Alison H. Watson, MD

New Drops on the Block – Updates in Glaucoma Medications • Natasha N. Kolomeyer, MD

The MIGS Pipeline • Aakriti G. Shukla, MD

Use of Video Games for the Treatment of Amblyopia • Jade M. Price, MD

Oxervate (Cenegermin) and ROCK Inhibitors for Corneal Disease • Zeba A. Syed, MD

Conclusion • Zeba A. Syed, MD

  Accreditation Statement: 

Wills Eye Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.

Credit Designation Statement:

Wills Eye Hospital designates this internet enduring material activity for a maximum of 1.00 AMA PRA Category 1 Credits.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Full disclosure policy:

All faculty participating in continuing medical education programs sponsored by Wills Eye Hospital are expected to disclose to the program audience any real or apparent conflict(s) of interest related to the content of their presentation(s).  Full disclosure will be made at the program.

If you have any questions, please contact the Wills Eye Hospital Department of CME at 215.440.3169 or         

To view this course, please log in or register.

Course Content

Multi-Disciplinary Update: Game Changers: Expanding Therapeutic Options Across the Subspecialties
Game Changers April 3 2020

Trending Topics
Retina Update- Looking Forward - The Next Decade in Retina (CME)
Anterior Segment Surgery Update (CME)
Meet The Experts (CME)
Oculoplastics Update - Eyelid and Lacrimal Problems (CME)
59 YO Male presents to the Wills ER for acute vision loss OD
Cornea Update: Window to Disease - Corneal Manifestations of Systemic Illness - (CME)
Game Changers: Expanding Therapeutic Options Across the Subspecialties (CME)
Chiefs Rounds: 90yo Caucasian woman w/ mild left side ocular/nasal pain & binocular horizonial diplopia x 1D
Chiefs Rounds: 23yo M onset diplopia from orbital floor fracture 5M ago
Chiefs Rounds Featured Case
What is the Diagnosis?
64yo man with shadows & cobwebs moving around his vision
Click Here to View Course
Live Streaming Chiefs' Rounds
Sony Vision Unimpaired
Center for Academic Global Ophthalmology